Brian Singerman joined Founders Fund in 2008. Brian relentlessly seeks out companies that can deliver massive returns to investors while also providing real value to humankind. He invests across sectors and stages, with a passion for companies reinventing huge industries like healthcare, biotechnology and education. Brian sits on the boards of Affirm, AltSchool, Emerald Therapeutics and Oscar. He was a board director at Misfit prior to the company’s acquisition by Fossil in 2015, and Stemcentrx before the company was acquired by AbbVie in 2016 in the largest private biotech acquisition of all time.
Prior to Founders Fund, Brian spent four years as an engineer and executive at Google. During this time Brian began investing through his own angel fund, The XGYC Fund. He began his career as an engineer at a startup, There, Inc. Brian graduated from Stanford University with a BS in Computer Science.